The medicine recommended by the WHO to treat covid in the elderly and cancer patients

The World Health Organization (WHO) recommended the drug Regenerate, as the third processing versus Covid-19, manufactured on the basis of synthetic antibodies and in particular for the elderly and people with immune problems.

The processing is recommended for patients “with non-severe symptoms of covid and at high risk of hospitalization ”, as is the case with the elderly or those with immunodeficiency problems (suffering from Cancer or have just undergone a transplantation, for example), according to the AFP agency. The recommendation of the experts of the WHO It was published in the medical journal The BMJ.

Then-US President Donald Trump accepted it processing still in the experimental phase when it was positive for covid-19, between September and October 2020.

The Regenerate it is also recommended for patients who are “seriously or critically ill and are seronegative, that is, they have not developed their own antibody response” to the infection.

“For all other types of patients covid-19, it is unlikely that the benefits of this processing antibodies are important, ”explained The BMJ in its press release. Designed by the biotechnology company Regenerate, the drug is marketed under the name Ronapreve by Roche.

He is processing combines two lab-made antibodies (called ‘monoclonal’), casirivimab and imdevimab. When injected intravenously, they help strengthen the immune system.